RNAWay
Herzliya, Tel Aviv, Israel
About RNAWay
RNAWay is an AgTech company developing RNA-based nanotechnology for treating viral infections and altering plant metabolic pathways. RNAWay is developing an RNA-based virus-control treatment to help senior winemakers and global crop protection companies recover reduced berry yield using sprayable, non-GMO technology. The company's technology is specific and targeted, therefore may be leveraged to treat other food crops such as Potatoes, Tomatoes, and Cannabis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Non-Equity Assistance (Jan 2022)
- Website: rnaway.com
Industries & Categories
AgTech, Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/rnaway-2469475 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.